The Role of Academic Institutions in the Development of Drugs for Rare and Neglected Diseases
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference42 articles.
1. Bulgarian funding agency accused of poor practice
2. Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years
3. Why rare diseases are an important medical and social issue
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. On Quality Standards and the Timing of Pharmaceutical Investment;2024
2. Public-private partnerships influencing the initiation and duration of clinical trials for neglected tropical diseases;PLOS Neglected Tropical Diseases;2023-11-13
3. Discovering Booming Bio-entities and Their Relationship with Funds;Data and Information Management;2021-06-26
4. Developing interactions with industry in rare diseases: lessons learned and continuing challenges;Genetics in Medicine;2020-01
5. The impact of the Orphan Drug Act on Food and Drug Administration-approved therapies for rare skin diseases and skin-related cancers;Journal of the American Academy of Dermatology;2019-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3